Is Axitinib a domestic drug or an imported drug?

Axitinib is an oral, small molecule tyrosine kinase inhibitor mainly used to treat advanced renal cell carcinoma. It was originally developed by Pfizer of the United States, so it is an imported original drug, not a domestic drug. In recent years, axitinib has been widely used around the world, and its efficacy has been verified by multiple clinical trials. As an original drug, it was first launched in developed countries such as Europe and the United States, and was later introduced to China.

Currently, axitinib has been successfully launched in China and has been included in the national medical insurance directory. Patients can purchase the drug with a prescription at regular domestic medical institutions and do not need to go through overseas purchasing channels. Domestic sales are mainly imported original drugs produced by Pfizer, whose specifications and efficacy are consistent with foreign versions. The medical insurance price of the original drug greatly reduces the patient's medication burden. Generally, the price after reimbursement by medical insurance is within a reasonable range. The unreimbursed price is about more than 4,000 yuan per box. The specific price needs to be determined according to local policies and hospital execution standards.

For patients who wish to further reduce medication costs, there are also some overseas generic versions that can be used as a reference. At present, countries such as India and Laos have produced generic drugs of axitinib. The ingredients of these generic versions are basically the same as those of the original drug, and their quality is also recognized internationally. The prices of the Indian and Lao versions are relatively affordable, usually only a few hundred yuan per box, making them an alternative choice for many patients with limited financial conditions. However, such generic drugs need to be obtained through formal channels to ensure safety and legality.

In general, axitinib is a foreign original drug. Although it is an imported drug in China, it has been marketed and included in medical insurance. Patients can purchase it directly in hospital pharmacies. If you choose a generic drug from India or Laos, you need to be careful to obtain it through reliable channels to balance the relationship between efficacy, safety and economic burden. For the specific usage of drugs and expense reimbursement details, it is recommended that patients consult the attending doctor and the hospital's medical insurance department.

Reference materials:https://en.wikipedia.org/wiki/Axitinib